Philips NV Stock
Stocks
PHIA
NL0000009538
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Euronext Amsterdam
11:55:00 2026-10-09 EDT
|
5-day change | 1st Jan Change | ||
| 21.78 EUR | +1.40% |
|
+2.40% | -6.28% |
| 10-09 | Philips NV : JP Morgan reiterates its Neutral rating | ZD |
| 10-08 | Royal Philips Announces Formation of Philips Sonicare Global Clinical Advisory Board | CI |
| Market Cap | 21.29B 23.84B 19.8B 18.01B 34.01B 2,307B 34.16B 238B 93.39B 1,176B 89.51B 87.55B 3,774B | P/E 2026 * |
17.8x | P/E 2027 * | 16.4x |
|---|---|---|---|---|---|
| Enterprise Value | 25.94B 29.04B 24.13B 21.95B 41.44B 2,811B 41.62B 290B 114B 1,433B 109B 107B 4,599B | EV / Sales 2026 * |
1.45x | EV / Sales 2027 * | 1.36x |
| Free-Float |
79.91% | Yield 2026 * |
3.95% | Yield 2027 * | 3.94% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Amsterdam
| PHIA | Real-time | |
CBOE
| PHIA | Real-time | |
|
OTC Markets
| RYLPF | Delayed | |
|
Wiener Boerse
| PHIA | End-of-day quote | |
|
Tradegate
| PHI1 | Real-time | |
|
Xetra
| PHI1 | Delayed | |
|
Boerse Muenchen
| PHI1 | Real-time | |
|
Börse Stuttgart
| PHI1 | Delayed | |
|
Deutsche Boerse AG
| PHI1 | Delayed | |
|
Borsa Italiana
| 1PHIA | End-of-day quote | |
|
London S.E.
| 0LNG | Delayed | |
|
CBOE
| 0LNG | Real-time |
Last Transcript: Philips NV
| 1 day | +1.40% | ||
| 1 week | +2.40% | ||
| Current month | +0.74% | ||
| 1 month | +2.25% | ||
| 3 months | -9.48% | ||
| 6 months | -10.26% | ||
| Current year | -6.28% |
| 1 week | 21.12 |  | 22.04 |
| 1 month | 21.1 | | 22.33 |
| Current year | 20.9 | | 27.7 |
| 1 year | 20.9 | | 27.7 |
| 3 years | 15.94 | | 30.22 |
| 5 years | 11.23 | | 38.88 |
| 10 years | 11.23 | | 47.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Roy Jakobs
CEO | Chief Executive Officer | 52 | 2022-10-14 |
| Director of Finance/CFO | 48 | 2024-09-30 | |
Willem Appelo
COO | Chief Operating Officer | 62 | 2022-07-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Paulus Stoffels
BRD | Director/Board Member | 64 | 2017-12-31 |
| Director/Board Member | 69 | 2019-05-09 | |
Feike Sijbesma
CHM | Chairman | 67 | 2021-05-05 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/1/25 | Exercice | Chief Executive Officer | 4,102 | 0.0004% | ||
| 11/1/25 | Exercice | Chief Executive Officer | 4,102 | 0.0004% | ||
| 10/29/25 | Exercice | Chief Executive Officer | 4,102 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.40% | +2.40% | -8.14% | +24.84% | 23.84B | |
| +0.93% | +0.49% | +25.38% | +32.63% | 243B | |
| +1.08% | +2.69% | +8.57% | +0.50% | 155B | |
| +2.06% | +8.17% | -1.31% | +42.35% | 150B | |
| +1.64% | +0.31% | -55.21% | -20.58% | 61.93B | |
| +1.15% | +0.07% | +15.24% | +16.87% | 49.12B | |
| +2.30% | +3.38% | -17.09% | -19.05% | 48.78B | |
| +1.41% | +1.65% | +24.83% | +50.53% | 48.08B | |
| +3.96% | +8.34% | +3.33% | +38.46% | 47.95B | |
| +1.08% | +2.01% | +31.05% | +61.37% | 42.62B | |
| Average | +1.70% | +2.78% | +2.66% | +22.79% | 86.99B | |
| Weighted average by Cap. | +1.50% | +2.74% | +7.22% | +23.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17.93B 20.07B 16.68B 15.17B 28.64B 1,943B 28.77B 201B 78.65B 990B 75.38B 73.73B 3,178B | 18.74B 20.98B 17.43B 15.85B 29.94B 2,031B 30.07B 210B 82.2B 1,035B 78.79B 77.06B 3,322B |
| Net income | 1.17B 1.32B 1.09B 994M 1.88B 127B 1.88B 13.15B 5.15B 64.9B 4.94B 4.83B 208B | 1.33B 1.49B 1.24B 1.13B 2.12B 144B 2.13B 14.89B 5.83B 73.47B 5.59B 5.47B 236B |
| Net Debt | 4.65B 5.21B 4.33B 3.93B 7.43B 504B 7.46B 52.06B 20.4B 257B 19.55B 19.12B 824B | 4.26B 4.77B 3.97B 3.61B 6.81B 462B 6.84B 47.73B 18.7B 236B 17.92B 17.53B 756B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-09 | €21.78 | +1.40% | 1,951,296 |
| 26-10-08 | €21.48 | -0.23% | 1,495,042 |
| 26-10-07 | €21.53 | -0.14% | 1,496,321 |
| 26-10-06 | €21.56 | +1.46% | 1,533,035 |
| 26-10-05 | €21.25 | -0.09% | 1,387,756 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PHIA Stock
Select your edition
All financial news and data tailored to specific country editions
